Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kanemura, Hoshimi ^a,b   Go, Masahiro J ^a   Shikamura, Masayuki ^a   Nishishita, Naoki ^a   Sakai, Noriko ^b   Kamao, Hiroyuki ^b,c   Mandai, Michiko ^b   Morinaga, Chikako ^b   Takahashi, Masayo ^b   Kawamata, Shin ^a,b  

^a FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NOD SCID GAMMA MOUSE; NOD SCID MOUSE; NONHUMAN; NUDE MOUSE; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; QUANTITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; STEM CELL TRANSPLANTATION;

ANIMALS; CARCINOGENESIS; FEMALE; HELA CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACULAR DEGENERATION; MICE; RATS; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84897979709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085336     Document Type: Article

References (21)

1. Lu B, Malcuit C, Wang S, Girman S, Francis P, et al. (2009) Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cell 27: 2126-2135.
2. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, et al. (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379: 713-720.
3. Diniz B, Thomas P, Thomas B, Ribeiro R, Hu Y, et al. (2013) Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci. 54: 5087-5096.
4. Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, et al. (2012) A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res. 48: 186-191.
5. Kuroda T, Yasuda S, Kusakawa S, Hirata N, Kanda Y, et al. (2012) Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PloS One 7: e37342.
6. Müller FJ, Goldmann J, Löser P, Loring JF (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell, 6: 412-414.
7. Prockop DJ (2010) Defining the probability that a cell therapy will produce a malignancy. Mol Ther. 18: 1249-1250.
8. World Health Organization (2010) "Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Proposed replacement of TRS 878, Annex 1.": 〈http://www.who.int/biologicals/ BS2132-CS-Recommendations-CLEAN-19-July-2010.pdf.〉
9. World Health Organization (2008) "Requirements for the use of animal cells as in vitro substrates for the production of biologicals. WHO Technical Report Series No.878, Annex 1.": 〈http://whglibdoc.who. int/trs/WHO-TRS-878.pdf.〉
10. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, et al. (2009) Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. (Amst.) 2: 198-210.
11. Bailey AM (2012) Balancing Tissue and Tumor Formation in Regenerative Medicine. Sci Transl Med. 4: 147fs28.
12. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol 26: 101-106.
13. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317. (Pubitemid 47080336)
14. Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, et al. (2011) Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474: 225-229.
15. Osakada F, Jin ZB, Hirami Y, Ikeda H, Danjyo T, et al. (2009) In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell. Sci 122: 3169-3179.
16. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
17. Okane H (2009) Strategies toward CNS-regeneration using induced pluripotent stem cells. Genome Informatics 217-220.
18. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain (null) mice. Blood, 106: 1565-1573. (Pubitemid 41208567)
19. Lewis AM (2005) "Regulatory Implications of Neoplastic Cell Substrat Tumorigenicity.": 〈http://www.fda.gov/ohrms/dockets/ac/05/slides/5- 4188S1-2.ppt.〉
20. Machida K, Suemizu H, Kawai K, Ishikawa T, Sawada R, et al. (2009) Higher susceptibility of NOG mice to xenotransplanted tumors. J. Toxicol. Sci 34: 123-127.
21. Kanemura H, Go JM, Nishishita N, Sakai N, Kamao H, et al. (2013) Pigment Epithelium-Derived Factor Secreted from Retinal Pigment Epithelium Facilitates Apoptotic Cell Death of iPSC. Scientific Reports 3: 2334.